CORNING INC /NY(GLW)— Stock Profile, AI Score & Financials
Materials · NYSE · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .
CORNING INC /NY (GLW) stock profile, AI quality score, and SEC EDGAR financial data, a Materials sector company. 13F Pro's AI-powered ranking engine scores GLW at 73.7/100 on a 32-signal composite quality model, placing it at rank #133 of 2,960 stocks — the top 5% of the AI-ranked universe. GLW scores in the top quartile across revenue scale (91.0), institutional flow (76.6). Shareholder dilution risk is elevated at 41.7/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2026), CORNING INC /NY reports quarterly revenue of $4.1B, net income of $371.0M, an operating margin of 15.4%. Top institutional holders of GLW by reported 13-F value include BlackRock, VANGUARD CAPITAL MANAGEMENT, STATE STREET, based on the most recent SEC filings. GLW trades on the NYSE exchange and files with the SEC under CIK 24741. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate GLW daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for CORNING INC /NY directly from SEC EDGAR.
AI Quality Score
73.7/100
AI Rank
#133
Revenue
$4.1B
Net Income
$371.0M
Operating Margin
15.4%
GLW key financials by period
CORNING INC /NY reported revenue, net income and margins by fiscal period, from SEC filings.
Period
Form
Revenue
Net income
Operating margin
FY 2025
10-K
$15.6B
$1.6B
14.6%
FY 2024
10-K
$13.1B
$506.0M
8.6%
FY 2023
10-K
$12.6B
$581.0M
7.1%
FY 2022
10-K
$14.2B
$1.3B
10.1%
FY 2021
10-K
$14.1B
$1.9B
15.0%
FY 2020
10-K
$11.3B
$512.0M
4.5%
Institutions holding GLW
Institutional investors reporting a position in CORNING INC /NY on SEC Form 13F.
AI-extracted from the 10-Q filed 2026-07-29 — Q2 2026 (quarter ended June 30, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.
Net sales rose 17% to $4,505M as optical communications products added $506M on Generative AI demand, while Corning booked a $1.0B AI-infrastructure customer deposit.
Biggest Revenue Drivers
Optical communications products$2,072M+$506M YoY
Continued growth in Enterprise business driven by strong demand for Generative AI products
Electronics glass and advanced optics products$1,230M
Glass Innovations segment cites continued strong demand for LCD glass
Biggest Revenue Drivers
Total revenue: $4,505M+17% YoY
Optical communications products$2,072M+$506M YoY
Continued growth in Enterprise business driven by strong demand for Generative AI products
Electronics glass and advanced optics products$1,230M
Glass Innovations segment cites continued strong demand for LCD glass
Automotive products$474M
Driven by the adoption of Corning's auto glass solutions
Polycrystalline silicon and solar products$438M+$207M YoY
Growth in polysilicon and solar wafers and module sales for the solar industry
Life Sciences products$249M
Life Sciences and Emerging Growth decline driven by Pharmaceutical Technologies business
Largest Expense Items
Cost of sales$2,877M+16% YoY
Primarily driven by the increase in net sales
Selling, general and administrative expenses$608M+18% YoY
Higher share-based compensation as a rising stock price increased fair value of performance-based restricted stock units
Research, development and engineering expenses$299M+8% YoY
Remained consistent at 7% of net sales
Amortization of purchased intangibles$23Mvs $28M prior-year quarter
Acquisition-related intangible amortization
Margins: Gross margin rose 17% to $1,628M but held flat at 36% of sales, as higher profit in Optical Communications was offset by temporarily higher costs to ramp Solar capacity.
Watch Items from the Filing
Recorded ~$0.7B net contract liability: a $1.0B customer deposit under a supply agreement through December 31, 2029, less a $296M warrant that will reduce future revenue.
Warrants issued May 6, 2026 for up to 18 million shares (15M at $180.00 strike, 3M pre-funded for $500M cash) create potential dilution.
Solar swung to a $7M segment net loss from $2M income on temporarily higher capacity ramp costs; 2026 capital expenditures expected to reach approximately $2.0 billion.
Life Sciences and Emerging Growth sales fell 15% to $294M with a $21M net loss, driven by the Pharmaceutical Technologies business.
Effective tax rate fell to 6.2% from 14.4%; restructuring, impairment and other charges of $71M were excluded from core results this quarter.
AI-extracted and verified against SEC EDGAR filing text. Not investment advice.
